@Strawman Any chance we can organise a meeting with Matthew at GLH? I think its one the crew would like. Bottom trawling op as they soon to complete the saas conversion and rebased the rest of the cost base as contracts implement and bill them. Post the product and cost side have adjustment, key may be to understand ongoing growth and longer term strategy to create value and get the stock re-rated as its very cheap atm even by micro/medtech shitco standards.

Email below if it helps. Mathew.cherian@global-health.com